Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. Far fewer people who could benefit from statins ...
Statins, which are prescription drugs that can reduce cholesterol levels and lower the risk for heart disease, don’t affect kidney function, new research shows. Investigators found that taking a ...
Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. It’s a math problem with life-and-death ...
Most people surveyed wouldn't be willing to take statins at their actual efficacy levels in primary prevention, according to a study with implications for shared decision-making. When informed about ...
Far fewer people who could benefit from statins actually take the cholesterol-lowering drugs now. Many who start taking them stop. The long list of side effects, detailed in fine print on package ...
EAST HANOVER, N.J., April 6, 2024 /PRNewswire/ -- Novartis today announced new data demonstrating the early addition of twice-yearly* Leqvio ® (inclisiran) to maximally tolerated statin therapy, prior ...
The polypill offers a cost-effective solution for CVD management in underserved populations, potentially reducing health disparities. The intervention is projected to cost $8560 per QALY gained, ...
Over the past several days, two major developments have emerged in the world of cholesterol-lowering therapies—specifically concerning the heavy-hitters known as PCSK9 inhibitors. In this letter, I’d ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results